Production of recombinant protein therapeutics in cultivated mammalian cells
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Cultivated mammalian cells have become the dominant system for the production of recombinant proteins for clinical applications because of their capacity for proper protein folding, assembly and post-translational modification. Thus, the quality and efficacy of a protein can be superior when expressed in mammalian cells versus other hosts such as bacteria, plants and yeast. Recently, the productivity of mammalian cells cultivated in bioreactors has reached the gram per liter range in a number of cases, a more than 100-fold yield improvement over titers seen for similar processes in the mid-1980s. This increase in volumetric productivity has resulted mainly from improvements in media composition and process control. Opportunities still exist for improving mammalian cell systems through further advancements in production systems as well as through vector and host cell engineering.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Advances in cell engineering, process control, and media composition are credited with improving the volumetric yield of cell culture bioprocesses, making biopharmaceutical manufacturing more cost-effective and practical [8].”
From The role of Raman spectroscopy in biopharmaceuticals from development to manufacturing (2022) · cites this paper as [8]
In the citing paper
“Chinese hamster ovary (CHO) cells are one of the main cell lines used in the production of recombinant therapeutics (Wurm, 2004; see Grillberger et al., 2009 for examples of proteins produced in CHO cells).”
From Virus susceptibility of Chinese hamster ovary (CHO) cells and detection of viral contaminations by adventitious agent testing (2010) · cites this paper as Wurm, 2004
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451 · cited 1×
“In 1973, Graham and van der Eb showed that exposing cells to nanoparticles of DNA and calcium phosphate makes possible DNA transfer into cultivated mammalian cell”
BackgroundEpigenetic Codes for Heterochromatin Formation and Silencing
Richards, E. J., & Elgin, S. C. R. (2002) · Cell · doi:10.1016/s0092-8674(02)00644-x · Cited by 871
Umaña, P., Jean–Mairet, J., Moudry, R., Amstutz, H., & Bailey, J. E. (1999) · Nature Biotechnology · doi:10.1038/6179 · Cited by 764
How introns influence and enhance eukaryotic gene expression
Le Hir, H., Nott, A., & Moore, M. J. (2003) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(03)00052-5 · Cited by 734
Bebbington, C. R., Renner, G., Thomson, S., King, D., Abrams, D., & Yarranton, G. T. (1992) · Nature Biotechnology · doi:10.1038/nbt0292-169 · Cited by 462 · cited 1×
“At a concentration of 10–100 μM MSX, resistant clones can be identified in selected NS0 cell populations that have amplified the transgene complex containing the GS gene and the desired gene(s) of interes”
BackgroundGenetic and physical linkage of exogenous sequences in transformed cells
Perucho, M., Hanahan, D., & Wigler, M. (1980) · Cell · doi:10.1016/0092-8674(80)90178-6 · Cited by 455 · cited 1×
“Nuclear ligases assure the covalent joining of individual plasmid DNA molecule”
BackgroundExpression of recombinant plasmids in mammalian cells Is enhanced by sodium butyrate
Gorman, C. M., Howard, B. H., & Reeves, R. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.21.7631 · Cited by 367 · cited 1×
“Another way to inhibit silencing is to block deacetylation of histones using butyrat”
BackgroundSilencing of transgene transcription precedes methylation of promoter DNA and histone H3 lysine 9
Mutskov, V., & Felsenfeld, G. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600013 · Cited by 296
Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998) · Biotechnology and Bioengineering · doi:10.1002/(sici)1097-0290(19980405)58:1<73::aid-bit8>3.0.co;2-r · Cited by 220 · cited 1×
“Thus, it might be advantageous to omit selective drugs once promising clonal cell lines have been identifie”
BackgroundLarge-scale transient expression in mammalian cells for recombinant protein production
Wurm, F., & Bernard, A. (1999) · Current Opinion in Biotechnology · doi:10.1016/s0958-1669(99)80027-5 · Cited by 203
Self-citation
Research works printed but not linked: 1
- Gorman, C.M., Howard, B.H. & Reeves, R. Expression of recombinant plasmids in mammalian cells is enhanced by sodium butyrate. Nucleic Acids Res. 11, 7631–7648 (1983). · DOI · Paper page
Cited by
Items 901–1,000 of 1,007
Quiroga-Campano, A. L., Panoskaltsis, N., & Mantalaris, A. (2018) · Metabolic Engineering · doi:10.1016/j.ymben.2018.02.013 · Cited by 21
Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9
Wang, W., Zheng, W., Hu, F., He, X., Wu, D., Zhang, W., Liu, H., & Ma, X. (2018) · ACS Synthetic Biology · doi:10.1021/acssynbio.7b00375 · Cited by 19
Analysis of intracellular IgG secretion in Chinese hamster ovary cells to improve IgG production
Kaneyoshi, K., Uchiyama, K., Onitsuka, M., Yamano, N., Koga, Y., & Ōmasa, T. (2018) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2018.06.018 · Cited by 20
Regl, C., Wohlschlager, T., Esser‐Skala, W., Wagner, I., Samonig, M., Holzmann, J., & Huber, C. G. (2019) · mAbs · doi:10.1080/19420862.2018.1563034 · Cited by 20
Du, C., Xu, J., Song, H., Tao, L., Lewandowski, A. T., Ghose, S., Borys, M., & Li, Z. J. (2019) · Process Biochemistry · doi:10.1016/j.procbio.2019.08.013 · Cited by 19
Schmitz, J., Täuber, S., Westerwalbesloh, C., von Lieres, E., Noll, T., & Grünberger, A. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27627 · Cited by 22
“As most bioproduction processes rely on in suspension growing cells (Wurm, 2004), results from single‐cell cultivation of adherent growing cells are of limited relevance for this application.”
BackgroundRaab, N., Zeh, N., Schlossbauer, P., Mathias, S., Lindner, B., Stadermann, A., Gamer, M., Fischer, S., Holzmann, K., Handrick, R., et al. (2021) · New Biotechnology · doi:10.1016/j.nbt.2021.10.005 · Cited by 20
Munro, T. P., Mahler, S. M., Huang, E. P., Chin, D. Y., & Gray, P. P. (2011) · mAbs · doi:10.4161/mabs.3.5.16968 · Cited by 19
“In industry, the two mostly commonly used auxotrophic selection techniques are the dihydrofolate reductase (DHFR) and glutamine synthetase (GS) systems.(28) When a plasmid encoding the DHFR enzyme is co-transfected with a gene of interest into DHFR-mutant CHO cells, e.”
BackgroundMethodInfluentialReisinger, H., Steinfellner, W., Katinger, H. W. D., & Kunert, R. (2009) · Cytotechnology · doi:10.1007/s10616-009-9224-x · Cited by 22
“More recently proto-oncogenes, cell cycle control genes, growth factor genes and anti-apoptotic genes have been used to improve production hosts or transient expression (Wurm 2004; Backliwal et al. 2008).”
BackgroundHong, W. W. L., & Wu, S. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.012 · Cited by 19
A cell sorting protocol for selecting high-producing sub-populations of Sf9 and High Five™ cells
Vidigal, J., Dias, M. M., Fernandes, F., Patrone, M., Bispo, C., Andrade, C., Gardner, R., Carrondo, M. J. T., Alves, P. M., & Teixeira, A. P. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.10.020 · Cited by 20
Monitoring CHO cell cultures: Cell stress and early apoptosis assessment by mass spectrometry
Schwamb, S., Munteanu, B., Meyer, B., Hopf, C., Hafner, M., & Wiedemann, P. (2013) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2013.10.014 · Cited by 21
Lee, J. S., Park, H. J., Kim, Y. H., & Lee, G. M. (2010) · PROTEOMICS · doi:10.1002/pmic.200900430 · Cited by 19
“One of the most frequently used approaches is the dihydrofolate reductase (DHFR)–methotrexate (MTX) gene amplification system [1].”
MethodToxin–antitoxin based transgene expression in mammalian cells
Nehlsen, K., Herrmann, S., Zauers, J., Häuser, H., & Wirth, D. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp1140 · Cited by 21
Genetic analysis of heterogeneous sub-clones in recombinant Chinese hamster ovary cells
Chen, K., Li, D., Li, H., Li, B., Li, J., Huang, L., Li, R., Xu, X., Jiang, L., Jiang, C., et al. (2017) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-017-8331-4 · Cited by 19
“…used mammalian cells for production of therapeutic recombinant proteins such as monoclonal antibodies, Fc fusion proteins, and cytokines that require glycosylation and proper folding for full biological activity (Butler and Meneses-Acosta 2012; Kim et al. 2012; Oberbek et al. 2011; Wurm 2004).”
Silkworm Storage Protein 1 Inhibits Autophagy-Mediated Apoptosis
Kang, S. J., & Rhee, W. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020318 · Cited by 20
Torres, M., Berríos, J., Rigual-Gonzalez, Y., Latorre, Y., Vergara, M., Dickson, A. J., & Altamirano, C. (2019) · Chemical Engineering Science · doi:10.1016/j.ces.2019.04.049 · Cited by 21
Eibl, R., & Eibl, D. (2008) · Advances in biochemical engineering, biotechnology · doi:10.1007/10_2008_3 · Cited by 22
He, Z., Sun, X., Mei, G., Yu, S., & Li, N. (2007) · Cell Biology International · doi:10.1016/j.cellbi.2007.12.003 · Cited by 19
“These disadvantages can be overcome by using a mammalian cell expression system (Wurm, 2004).”
BackgroundMariati, Koh, E. Y. C., Yeo, J. H. M., Ho, S. C. L., & Yang, Y. (2014) · Bioengineered · doi:10.4161/bioe.32111 · Cited by 20
“2 Extensive studies have indicated that production instability is caused by two major mechanisms: (1) loss of transgene copies, and (2) transcriptional silencing of promoters.”
Cell Culture Processes in Monoclonal Antibody Production
Li, F., Shen, A. Y., & Amanullah, A. (2013) · Wiley eBooks · doi:10.1002/9780470571224.pse506 · Cited by 21
Molecular farming of antibodies in plants
Twyman, R. M., Schillberg, S., & Fischer, R. (2007) · Springer eBooks · doi:10.1007/978-1-4020-5486-0_15 · Cited by 19
Minervini, M., Behboudi, A., Marzella, J. R., & Zydney, A. L. (2024) · Separation and Purification Technology · doi:10.1016/j.seppur.2024.126574 · Cited by 18
Lanvers, P., Broeker, J., & Schmid, J. (2025) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2025.123783 · Cited by 19
Lispi, M., Datola, A., Bierau, H., Ceccarelli, D., Crisci, C., Minari, K., Mendola, D., Regine, A., Ciampolillo, C., Rossi, M., et al. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21774 · Cited by 18
“In general, mammalian protein expression systems can be considered as more advanced since they ensure correct protein folding as well as transcriptional, translational and posttranslational modifications.(9) Recently, the European Agency for the Evaluation of Medicinal Products (EMEA) and the European Commission (EC)…”
BackgroundZhang, Z., Li, S., Chen, N., Yang, C., & Wang, Y. (2013) · Biomacromolecules · doi:10.1021/bm400096z · Cited by 18
Roointan, A., & Morowvat, M. H. (2016) · Biotechnology and Genetic Engineering Reviews · doi:10.1080/02648725.2016.1270095 · Cited by 18
“…and energy metabolism in yeast cells (Delic, Göngrich, Mattanovich, & Gasser, 2014; Delic et al., 2013; Klein, Niklas, & Heinzle, 2015), or due to instability and low culture life of mammalian cell lines (Arden & Betenbaugh, 2004; Niklas, Nonnenmacher, Rose, Sandig, & Heinzle, 2011; Wurm, 2004).”
BackgroundSuzuki, T., Baba, S., Ono, M., Nonaka, K., Ichikawa, K., Yabuta, M., Ito, R., & Chiba, Y. (2017) · Journal of Bioscience and Bioengineering · doi:10.1016/j.jbiosc.2017.03.001 · Cited by 18
Wang, Z., Zuo, F., Liu, Q., Wu, X., Du, Q., Lei, Y., Wu, Z.-M., & Lin, H. (2021) · ACS Omega · doi:10.1021/acsomega.0c06187 · Cited by 19
Intracellular Protein–Drug Interactions Probed by Direct Mass Spectrometry of Cell Lysates
Rogawski, R., Rogel, A., Bloch, I., Gal, M., Horovitz, A., London, N., & Sharon, M. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202104947 · Cited by 20
Heng, Z. S., Yeo, J. Y., Koh, D. W., Gan, S. K., & Ling, W. (2022) · Antibody Therapeutics · doi:10.1093/abt/tbac003 · Cited by 21
“Currently, whole recombinant antibodies are predominantly produced by mammalian cells, given the need for complex folding, assembly and post-translational modifications to generate functionally active proteins [3, 4].”
BackgroundMammalian Cell Culture Technology: An Emerging Field
Eibl, D., Eibl, R., & Pörtner, R. (2009) · Principles and practice · doi:10.1007/978-3-540-68182-3_1 · Cited by 20
“Genetic engineering has contributed significantly to the recent progress in this area (Korke et al. 2002; Wurm 2004; Butler 2005).”
BackgroundIntegrated approach to produce a recombinant, his‐tagged human α‐galactosidase a in mammalian cells
Corchero, J. L., Mendoza, R., Lorenzo, J., Rodríguez‐Sureda, V., Domı́nguez, C., Vázquez, E., Ferrer‐Miralles, N., & Villaverde, A. (2011) · Biotechnology Progress · doi:10.1002/btpr.637 · Cited by 18
“In this study, we used a recombinant human a-galactosidase A enzyme (GLA; EC 3.2.1.22) as a protein model to study and optimize an integrated approach for its production in mammalian cells by TGE.”
BackgroundResultInfluentialAdam, E., Sarrazin, S., Landolfi, C., Motte, V., Lortat‐Jacob, H., Lassalle, P., & Delehedde, M. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.141 · Cited by 18
Protein and Genome Evolution in Mammalian Cells for Biotechnology Applications
Majors, B. S., Chiang, G. G., & Betenbaugh, M. J. (2009) · Molecular Biotechnology · doi:10.1007/s12033-009-9156-x · Cited by 18
“Two traits including high productivity and bioreactor operating longevity are useful for attaining gram per liter production levels [4].”
BackgroundPristovšek, N., Hansen, H. G., Sergeeva, D., Borth, N., Lee, G. M., Andersen, M. R., & Kildegaard, H. F. (2018) · Biotechnology Journal · doi:10.1002/biot.201700216 · Cited by 19
Robotic selection for the rapid development of stable CHO cell lines for HIV vaccine production
O’Rourke, S. M., Byrne, G., Tatsuno, G. P., Wright, M., Yu, B., Mesa, K. A., Doran, R. C., Alexander, D. L., & Berman, P. W. (2018) · PLoS ONE · doi:10.1371/journal.pone.0197656 · Cited by 18
Efficient Expression from One CMV Enhancer Controlling Two Core Promoters
Andersen, C. R., Nielsen, L. S., Baer, A. S., Tolstrup, A. B., & Weilguny, D. (2010) · Molecular Biotechnology · doi:10.1007/s12033-010-9353-7 · Cited by 20
“For commercial expression of antibodies, stable producer cells are used [ 24 ].”
MethodManufacture of Recombinant Biopharmaceutical Proteins by Cultivated Mammalian Cells in Bioreactors
Wurm, F. M. (2005) · Wiley eBooks · doi:10.1002/9783527620982.ch31 · Cited by 17
Self-citationNordin, F., Ahmad, R. N. R., & Farzaneh, F. (2017) · Virus Research · doi:10.1016/j.virusres.2017.04.007 · Cited by 18
Yanaka, S., Yagi, H., Yogo, R., Onitsuka, M., & Kato, K. (2022) · Journal of Biomolecular NMR · doi:10.1007/s10858-021-00387-5 · Cited by 17
“On the other hand, methods for cell culture under glutamine-free conditions were developed through introduction of glutamine synthase to cell lines (Carinhas et al. 2013; Nakamura and Omasa 2015; Wurm 2004).”
MethodHeterologous Protein Expression
McDonald, K. A. (2011) · Elsevier eBooks · doi:10.1016/b978-0-08-088504-9.00114-8 · Cited by 19
Jiang, B., Argyros, R., Bukowski, J. T., Nelson, S., Sharkey, N., Kim, S., Copeland, V., Davidson, R. C., Chen, R., Zhuang, J., et al. (2014) · Applied and Environmental Microbiology · doi:10.1128/aem.02619-14 · Cited by 21
“Such dramatic yield improvements have been attributed to advances enabling the growth of mammalian cell cultures to very high densities (10(5) to 10(7) cells per ml), and, more importantly, the ability to maintain high levels of cell viability for extended times (from 100 h to 400 h) (28).”
BackgroundPohlscheidt, M., Charaniya, S., Kulenovic, F., Corrales, M., Shiratori, M., Bourret, J., Meier, S. J., Fallon, E., & Kiss, R. (2013) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-013-5451-3 · Cited by 17
“Mammalian cells are the expression systems of choice due to their ability to properly fold and modify these complex proteins and antibodies (Xie andWang 1997; Qi et al. 2003; Wurm 2004; Sethuramann and Stadheim 2006).”
BackgroundNg, S. K., Tan, T. R. M., Wang, Y., Ng, D., Goh, L., Bardor, M., Wong, V. V. T., & Lam, K. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052785 · Cited by 17
“To achieve a high-titer production of recombinant proteins, the mammalian cell expression system popularly used in the biopharmaceutical industry is the methotrexate (MTX) amplification system [24–26].”
MethodDharshanan, S., Chong, H., Cheah, S. H., & Zamrod, Z. (2013) · Cytotechnology · doi:10.1007/s10616-013-9615-x · Cited by 19
“These are major considerations especially if these mAbs are intended for repeated use as therapeutic agents in humans (Wurm 2004).”
BackgroundNoncoding RNAs, post-transcriptional RNA operons and Chinese hamster ovary cells
Stiefel, F., Fischer, S., Hackl, M., Handrick, R., Hesse, F., Borth, N., Otte, K., & Grillari, J. (2015) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.65 · Cited by 17
Bioinspired affinity DNA polymers on nanoparticles for drug sequestration and detoxification
Chen, N., Huang, Y., & Wang, Y. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.08.017 · Cited by 17
“Second, recent advances in biotechnology have enabled the large-scale production of various highly potent biologics such as growth factors, cytokines and vaccines [44,45].”
BackgroundGreenham, T. J., & Altosaar, I. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-194-3_22 · Cited by 20
Padhiar, A. A., Chanda, W., Joseph, T. P., Guo, X., Liu, M., Sha, L., Batool, S., Gao, Y., Zhang, W., Huang, M., et al. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-8754-6 · Cited by 17
“Other expression systems such as yeast (Gasser et al. 2013), baculorvirus/ insect, or transformed mammalian cell expression systems (Wurm 2004) can produce active and post-translationally modified proteins, but their disadvantages, including lower yield with higher experimental cost or the…”
BackgroundTang, D., Subramanian, J., Haley, B., Baker, J. J., Luo, L., Hsu, W., Liu, P., Sandoval, W. N., Laird, M. W., Snedecor, B., et al. (2018) · Biotechnology Journal · doi:10.1002/biot.201800332 · Cited by 17
Vector-related stratagems for enhanced monoclonal antibody production in mammalian cells
Gupta, K., Parasnis, M. S., Jain, R. D., & Dandekar, P. P. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107415 · Cited by 18
Samy, A., Kaneyoshi, K., & Ōmasa, T. (2020) · Biotechnology Journal · doi:10.1002/biot.201900352 · Cited by 20
An amplitude equation modelling the double-crest swirling in orbital-shaken cylindrical containers
Bongarzone, A., Guido, M., & Gallaire, F. (2022) · Journal of Fluid Mechanics · doi:10.1017/jfm.2022.440 · Cited by 17
“It is used in biological and chemical industrial applications, notably bacterial and cellular cultures (McDaniel & Bailey 1969; Wurm 2004), as an alternative to stirred tanks, where liquid agitation results from a rotating impeller or the rotation of a magnetic rod.”
BackgroundMethodRojek, J., Basavaraju, Y., Nallapareddy, S., Bulté, D. B., Baumgartner, R., Schoffelen, S., Grav, L. M., Goletz, S., & Pedersen, L. E. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28367 · Cited by 17
“As a result, the arbitrary nature of integration sites and their variable accessibility for gene expression may lead to clonal instability and loss of productivity (Bandyopadhyay et al., 2019; Vcelar et al., 2018; Wilson et al., 1990; Wurm, 2004).”
BackgroundHan, F., Kang, L., Zeng, X., Ye, Z., Guo, L., & Lin, J. (2014) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6562 · Cited by 17
Zhao, Y., Xing, J., Xing, J. Z., Ang, W. T., & Chen, J. (2014) · Ultrasonics · doi:10.1016/j.ultras.2014.04.025 · Cited by 17
Cartwright, J. F., Anderson, K., Longworth, J., Lobb, P., & James, D. C. (2018) · Biotechnology and Bioengineering · doi:10.1002/bit.26561 · Cited by 18
“However, immortal mammalian cell lines are well known for being heterogeneous, due to their underlying genetic instability, which is perhaps an inevitable phenotype for immortal cells (Feichtinger et al., 2016; Wurm, 2004; Wurm & Hacker, 2011).”
BackgroundProcess Economic Drivers in Industrial Monoclonal Antibody Manufacture
Farid, S. S. (2008) · Wiley eBooks · doi:10.1002/9780470444894.ch12 · Cited by 17
Kim, H.-Y., Tsai, S., Lo, S., Wear, D. J., & Izadjoo, M. J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019867 · Cited by 17
“Recent progresses in antibody engineering, cell transfection technology, and expression systems containing selective markers allow highly efficient transfection of mammalian cells for the fast production of neutralizing cMAbs [31,38] The efficient transfection of cells not only facilitates stable cell clone generation…”
BackgroundO’Connor, S. K., Li, E., Majors, B. S., He, L., Placone, J. K., Baycin, D., Betenbaugh, M. J., & Hristova, K. A. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.04.007 · Cited by 25
“Here we examine the expression of the integral membrane protein ErbB2 in CHO cells, which are widely used for the production of secreted recombinant proteins in commercial applications [18].”
BackgroundProcess intensification for the production of rituximab by an inducible CHO cell line
Mellahi, K., Brochu, D., Gilbert, M., Perrier, M., Ansorge, S., Durocher, Y., & Henry, O. (2019) · Bioprocess and Biosystems Engineering · doi:10.1007/s00449-019-02075-z · Cited by 17
Adebar, N., Arnold, S., Herrera, L. M., Emenike, V. N., Wucherpfennig, T., & Smiatek, J. (2024) · Biotechnology and Bioengineering · doi:10.1002/bit.28851 · Cited by 16
“Hence, monoclonal antibodies (mAbs), along with other biotherapeutic drugs, are routinely expressed in mammalian cell cultures, thereby circumventing many of the problems inherent in simpler bacterial growth processes (Heistinger et al., 2021; O'Flah-erty et al., 2020; Wurm, 2004).”
Betts, Z., & Dickson, A. J. (2015) · Biotechnology Journal · doi:10.1002/biot.201500159 · Cited by 17
“Despite recent improvements in bacterial and yeast cell platforms, mammalian cells, in particular CHO cells remain the most widely used host cell platform for producing therapeutic proteins requiring complex posttranslational modifications [1, 2].”
BackgroundInsight into the roles of tyrosine on rCHO cell performance in fed-batch cultures
Tang, H., Zhang, X., Zhang, W., Li, F., Wang, H., Tan, W., & Zhao, L. (2019) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-019-09921-w · Cited by 19
Song, S., Diao, H., Moon, B., Yun, A., & Hwang, I. (2022) · Frontiers in Plant Science · doi:10.3389/fpls.2022.878677 · Cited by 20
“Animal cells are largely used for therapeutic proteins (Wurm, 2004; Grillberger et al., 2009).”
Backgroundl-Lactate treatment by photosynthetic cyanobacteria expressing heterogeneous l-lactate dehydrogenase
Kato, Y., Inabe, K., Haraguchi, Y., Shimizu, T., Kondo, A., & Hasunuma, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-34289-3 · Cited by 16
Raab, N., Zeh, N., Kretz, R., Weiß, L., Stadermann, A., Lindner, B., Fischer, S., Stoll, D., & Otte, K. (2024) · Metabolic Engineering · doi:10.1016/j.ymben.2024.03.007 · Cited by 16
Structural Biology of Glycoproteins
Joanne, E. (2012) · InTech eBooks · doi:10.5772/48154 · Cited by 16
“Formation of a stable cell line producing a glycoprotein of interest often gives higher yields than utilizing transient transfection, however establishment of a stable cell line can take 2-6 months [41].”
BackgroundWhy Proteins in Mammalian Cells?
Hartley, J. L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-352-3_1 · Cited by 18
Green, J. L., Bauer, M., Yum, K. W., Li, Y., Cox, M. L., Willert, K., & Wahl, G. M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058395 · Cited by 17
“CHO cells reliably generate high protein yields, can be grown at high-density under chemically defined conditions and are adaptable to suspension culture, thus permitting large scale production in bioreactors [17].”
Expression of biologically active human interferon alpha 2b in the milk of transgenic mice
Li, H., Liu, Q., Cui, K., Liu, J., Ren, Y., & Shi, D. (2012) · Transgenic Research · doi:10.1007/s11248-012-9623-1 · Cited by 16
“Human and other mammalian cells were also used to produce secreted recombinant proteins such as anti-bodies (Grunberg et al. 2003; Wurm 2004; Loignon et al. 2008), and possess the ability of post-translational modifications.”
BackgroundLiu, X. M., Liu, H., Wu, B. C., Li, S. C., Ye, L. L., Wang, Q. W., Huang, P., & Chen, Z. L. (2006) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-006-0409-3 · Cited by 16
“Suspension cultivation of animal cells is the preferred method for mass production of recombinant proteins and vaccines (Wurm 2004; Butler 2005).”
BackgroundMethodHogwood, C. E. M., Ahmad, S. S., Tarrant, R. D. R., Bracewell, D. G., & Smales, C. M. (2015) · Biotechnology Journal · doi:10.1002/biot.201500010 · Cited by 18
“The manufacture of biotherapeutic proteins using mammalian cell line expression systems is well established and productivities of >5–10 g/L have now been reported [1, 2].”
BackgroundCodon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein
Zucchelli, E., Pema, M., Stornaiuolo, A., Piovan, C., Scavullo, C., Giuliani, E., Bossi, S., Corna, S., Asperti, C., Bordignon, C., et al. (2017) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2017.01.002 · Cited by 16
Kastelic, M., Kopač, D., Novak, U., & Likozar, B. (2018) · Biochemical Engineering Journal · doi:10.1016/j.bej.2018.11.015 · Cited by 17
Zhao, S., Smits, C. B., Schuurman, N., Barnum, S. M., Pusterla, N., van Kuppeveld, F. J. M., Bosch, B., van Maanen, K., & Egberink, H. F. (2019) · Viruses · doi:10.3390/v11121109 · Cited by 17
“, glycosylation) are mimicking the S proteins on the surface of virus particles [29].”
BackgroundWang, Y., Qiu, H., Minshull, J., Tam, W., Hu, X., Mieczkowski, C., Zheng, W., Chu, C., Liu, W., Boldog, F. L., et al. (2022) · Biochemical Engineering Journal · doi:10.1016/j.bej.2022.108683 · Cited by 16
Expression of Antibody in Mammalian Cells
Jostock, T. (2011) · Cell engineering · doi:10.1007/978-94-007-1257-7_1 · Cited by 24
Huang, N.-C., Sieber, M. A., & Hsu, S. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.09.013 · Cited by 16
Effects of Lonomia obliqua caterpillar venom upon the proliferation and viability of cell lines
Heinen, T. E., de Farias, C. B., Abujamra, A. L., Mendonça, R. Z., Roesler, R., & da Veiga, A. B. G. (2013) · Cytotechnology · doi:10.1007/s10616-013-9537-7 · Cited by 16
“Culture of mammalian cells represent a major resource for producing high-value biotherapeutic drugs (Wurm 2004), which includes monoclonal antibodies (Rycyzyn et al.”
BackgroundRodrigues, M. E., Costa, A. R., Fernandes, P., Henriques, M., Cunnah, P., Melton, D. W., Azeredo, J., & Oliveira, R. (2013) · Journal of Microbiology and Biotechnology · doi:10.4014/jmb.1304.04011 · Cited by 17
“However, it is not always feasible to switch cells from their normal anchorage-dependent growth [44] to suspended culture, and the use of adherent cells is sometimes preferred for certain applications (e.”
BackgroundVoronina, E. V., Seregin, Y. A., Litvinova, N. А., Shvets, V. I., & Shukurov, R. R. (2016) · SpringerPlus · doi:10.1186/s40064-016-3213-2 · Cited by 16
“2007; Nasonov 2007; Scott and Kingsley 2006; Wurm 2004; Chu and Robinson 2001).”
BackgroundHarrison, R. P., & Chauhan, V. M. (2017) · Biointerphases · doi:10.1116/1.5013335 · Cited by 16
Modeling Genetic Circuit Behavior in Transiently Transfected Mammalian Cells
Wang, J., Isaacson, S. A., & Belta, C. A. (2019) · ACS Synthetic Biology · doi:10.1021/acssynbio.8b00166 · Cited by 16
Production of Therapeutic Antibodies in Plants
Twyman, R. M., Schillberg, S., & Fischer, R. (2006) · Wiley eBooks · doi:10.1002/9783527619771.ch14 · Cited by 15
Sacco, S. A., Tuckowski, A. M., Trenary, I. A., Kraft, L., Betenbaugh, M. J., Young, J. D., & Smith, K. D. (2022) · Biotechnology and Bioengineering · doi:10.1002/bit.28084 · Cited by 16
“…their complexity, biopharmaceuticals are typically produced in mammalian cell cultures; in particular, Chinese hamster ovary (CHO) cells are considered the “workhorses” of the biopharma industry, as they are used to produce nearly 70% of all protein therapeutics (De Jesus & Wurm, 2011; Wurm, 2004).”
BackgroundCasteleijn, M. G., Abendroth, U., Zemella, A., Walter, R., Rashmi, R., Haag, R., & Kubick, S. (2025) · Chemical Reviews · doi:10.1021/acs.chemrev.4c00126 · Cited by 17
Wingens, M., Gätgens, J., Schmidt, A., Albaum, S. P., Büntemeyer, H., Noll, T., & Hoffrogge, R. (2015) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2015.01.005 · Cited by 18
Integrated process design for single‐cell analytical technologies
Love, J. C. (2010) · AIChE Journal · doi:10.1002/aic.12413 · Cited by 15
Cao, Y., Kimura, S., Itoi, T., Honda, K., Ohtake, H., & Ōmasa, T. (2011) · Methods · doi:10.1016/j.ymeth.2011.11.002 · Cited by 15
Misaghi, S., Shaw, D., Louie, S., Nava, A., Simmons, L. C., Snedecor, B., Poon, C., Paw, J. S., Appling, L. L., & Cupp, J. E. (2015) · Biotechnology Progress · doi:10.1002/btpr.2204 · Cited by 15
“express the target proteins at high titers and in serum-free media at high densities in suspension.(1,2) This process”
BackgroundTracking dipeptides at work-uptake and intracellular fate in CHO culture
Sánchez-Kopper, A., Becker, M., Pfizenmaier, J., Keßler, C. S., Karau, A., & Takors, R. (2016) · AMB Express · doi:10.1186/s13568-016-0221-0 · Cited by 15
“To cope with market demands, productivity of CHO-based mAb production has risen more than 100-fold since the 1990s (Birch and Racher 2006; Wurm 2004), currently reaching 2–5 g/L (and more) in 12 day-cultivations (Schaub et al.”
BackgroundWinstel, R., Wieland, J., Gertz, B., Mueller, A., & Allgaier, H. (2017) · Drugs in R&D · doi:10.1007/s40268-017-0182-z · Cited by 15
“Chinese Hamster Ovary [CHO] cells) with the human FSH gene; (ii) clonal selection and isolation of the production cell line; (iii) cell banking to provide a supply of cell substrate from the selected clone for continued manufacture of the product; and (iv) large-scale production processes involving fermentation and pu…”
BackgroundThe Production of Human β-Glucocerebrosidase in Nicotiana benthamiana Root Culture
Uthailak, N., Ohashi, T., Misaki, R., & Fujiyama, K. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19071972 · Cited by 16
Yamano, N., & Ōmasa, T. (2018) · Cytotechnology · doi:10.1007/s10616-018-0243-3 · Cited by 16
“Protein production stability during long-term culture is a major issue in the biopharmaceutical industry, and one of the main concerns in this area is CpGmethylation in the promoter region of the transgene (Barnes et al. 2003; Wurm 2004).”
BackgroundDevelopment of rolled scaffold for high-density adherent cell culture
YekrangSafakar, A., Hamel, K. M., Mehrnezhad, A., Jung, J. P., & Park, K. (2019) · Biomedical Microdevices · doi:10.1007/s10544-019-0459-9 · Cited by 15
Sagandykova, G. N., Pomastowski, P., & Buszewski, B. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.115865 · Cited by 18
Perfusion Cell Culture Processes for Biopharmaceuticals: Process Development, Design, and Scale-up
Wolf, M., Bielser, J., & Morbidelli, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108847209 · Cited by 18
Klingler, F., Mathias, S., Schneider, H., Buck, T., Raab, N., Zeh, N., Shieh, Y., Pfannstiel, J., & Otte, K. (2021) · Biotechnology and Bioengineering · doi:10.1002/bit.27811 · Cited by 15
“for the cultured cells to grow in suspension, stay viable, and produce desired products at high titers and quality (Kunert & Reinhart, 2016; Wurm, 2004).”
Background
Metadata
- Authors
- Wurm, F. M.
- Affiliations
- École Polytechnique Fédérale de Lausanne (CH)
- Corresponding author
- Wurm, Florian M
- ORCID
- Wurm, Florian M
- Venue
- Nature Biotechnology
- Published
- 2004-11
- Volume
- 22
- Issue
- 11
- Pages
- 1393-1398
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2118540273
- Cited by
- 2,032
- References
- 52
- Citations by year
- 2026: 52 · 2025: 51 · 2024: 66 · 2023: 66 · 2022: 64 · 2021: 77 · 2020: 89 · 2019: 114 · 2018: 162 · 2017: 118 · 2016: 95 · 2015: 135 · 2014: 108 · 2013: 145 · 2012: 111
- FWCI
- 3.67
- Type
- journal article
- Language
- en
- Open access
- green
- infoscience.epfl.ch
- Licence
- cc-by-nc-nd
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Infoscience (Ecole Polytechnique Fédérale de Lausanne) (submittedVersion, cc-by-nc-nd)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Viral Infectious Diseases and Gene Expression in Insects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein purification and stability
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Transgenic Plants and Applications
- Keywords
- recombinant therapeutic proteins, mammalian cell culture, bioreactors, protein folding, post-translational modification, volumetric productivity, culture medium optimization, process control, vector engineering, host cell engineering
- MeSH terms
- Animals, Cells, Cultured, Humans, Mammals, Recombinant Proteins, Transfection, Protein Engineering, Cell Culture Techniques, Bioreactors, Genetic Enhancement
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.